# Dawn L. Hershman

Source: https://onco.cc/people/dawn-hershman/  
OnCo record `dawn-hershman` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Breast oncologist who co-leads SWOG and studies adherence, toxicity, and how care is actually delivered.

## Summary

Dawn Hershman is Group Co-Chair of the SWOG Cancer Research Network and Professor of Medicine and Epidemiology at Columbia University. A breast medical oncologist and health outcomes researcher, she co-chairs SWOG with Primo Lara and has led its cancer care delivery research and trials on chemotherapy-induced neuropathy and endocrine therapy adherence. Her papers include a JAMA randomised trial of acupuncture for aromatase inhibitor related joint pain in early-stage breast cancer and a Journal of Clinical Oncology cohort study of early discontinuation and nonadherence to adjuvant hormonal therapy. Her work spans triple-negative and HR-positive breast cancer, care delivery and survivorship.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Group Co-Chair, SWOG Cancer Research Network; Professor of Medicine and Epidemiology, Columbia University
- Specialisms: Breast cancer; Cancer care delivery; Survivorship

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/Dawn_L._Hershman
- SWOG leadership: https://www.swog.org/about/leadership
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Hershman%20DL%5BAuthor%5D
- Google Scholar: https://scholar.google.com/scholar?q=Dawn%20L.%20Hershman

## Connected records

- cancers: [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/), [Triple-negative breast cancer (TNBC)](https://onco.cc/cancers/tnbc/)
- companies: [SWOG Cancer Research Network](https://onco.cc/companies/swog/)
- institutions: [Herbert Irving Comprehensive Cancer Center, Columbia University](https://onco.cc/institutions/columbia-hicc/)

---
JSON: https://onco.cc/api/v1/entities/dawn-hershman.json